Branched chain amino acids in the management of chronic liver disease. Facts and fantasies.

No abstract is available for this paper.

• Publication year

  1990

• Venue

  Journal of Hepatology

• Publication date

  1990-09-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/0168-8278(90)90103-XPMID 2254623
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Treatment of acute hepatic encephalopathy in cirrhotics with a branched-chain amino acids enriched versus a conventional amino acids mixture. A controlled study of 70 patients.

  2008cited by this paper
• Is Intravenous Administration of Branched Chain Amino Acids Effective in the Treatment of Hepatic Encephalopathy? A Multicenter Study

  2007cited by this paper
• Anticatabolic Effect of Branched‐Chain Amino Acid‐Enriched Solutions in Patients with Liver Cirrhosis

  2007cited by this paper
• Long-term oral branched-chain amino acid treatment in chronic hepatic encephalopathy: A randomized double-blind casein-controlled trial☆

  1990cited by this paper
• Long-term oral branched-chain amino acid treatment in chronic hepatic encephalopathy. A randomized double-blind casein-controlled trial. The Italian Multicenter Study Group.

  1990cited by this paper
• Branched‐chain amino acids in the management of hepatic encephalopathy: An analysis of variants

  1989cited by this paper
• Parenteral nutrition with branched-chain amino acids in hepatic encephalopathy. A meta-analysis.

  1989cited by this paper
• Elevated protein requirements in cirrhosis of the liver investigated by whole body protein turnover studies.

  1988cited by this paper
• Enriched branched-chain amino acid formula versus a casein-based supplement in the treatment of cirrhosis.

  1985cited by this paper
• Branched chain amino acids in the treatment of latent portosystemic encephalopathy. A double-blind placebo-controlled crossover study.

  1985cited by this paper
• Disease-specific amino acid infusion (F080) in hepatic encephalopathy: a prospective, randomized, double-blind, controlled trial.

  1985cited by this paper
• Standard or branched-chain amino acid infusions as short-term nutritional support in liver cirrhosis?

  1985cited by this paper
• Hepatic Encephalopathy in Chronic Liver Failure

  1984cited by this paper
• Long Term Dietary Supplement with Branched Chain Amino Acids: A New Approach in the Prevention of Hepatic Encephalopathy: Results of a Controlled Study in Cirrhotics with Porto-Caval Anastomosis

  1984cited by this paper
• Comparison of Dietary Protein with an Oral, Branched Chain‐Enriched Amino Acid Supplement in Chronic Portal‐Systemic Encephalopathy: A Randomized Controlled Trial

  1984cited by this paper
• Branched-chain amino acid-enriched elemental diet in patients with cirrhosis of the liver. A double blind crossover trial.

  1983cited by this paper
• Comparison of the Effects of Hepatic‐Aid and a Casein Modular Diet on Enceph‐alopathy, Plasma Amino Acids, and Nitrogen Balance in Cirrhotic Patients

  1983cited by this paper
• Effect of a branched chain amino acid-enriched nutritional product on the pathophysiology of the liver and nutritional state of patients with liver cirrhosis.

  1983cited by this paper
• Metabolism and Clinical Implications of Branched Chain Amino and Keto Acids

  1982cited by this paper
• Branched-chain amino acids vs lactulose in the treatment of hepatic coma

  1982cited by this paper
• Branched-chain amino acids in the treatment of chronic hepatic encephalopathy.

  1982cited by this paper
• Plasma amino-acid patterns in liver disease.

  1982cited by this paper
• Influence of an orally administered protein mixture enriched in branched chain amino acids on the chronic hepatic encephalopathy (CHE) of patients with liver cirrhosis.

  1981cited by this paper
• HYPERAMMONÆMIA, PLASMA AMINOACID IMBALANCE, AND BLOOD-BRAIN AMINOACID TRANSPORT: A UNIFIED THEORY OF PORTAL-SYSTEMIC ENCEPHALOPATHY

  1979cited by this paper
• Comparison of lactulose and neomycin in the treatment of chronic portal-systemic encephalopathy. A double blind controlled trial.

  1977cited by this paper
• False neurotransmitters and hepatic failure.

  1971cited by this paper
• A Controlled Study

  1966cited by this paper

• Medical interventions for prevention and treatment of hepatic encephalopathy in adults with cirrhosis: a network meta-analysis

  2018cites this paper
• OPTICAL INTEGRATING CAVITY LIGHTING SYSTEMUSING MULTIPLE LED LIGHT SOURCES

  2017cites this paper
• Hepatic encephalopathy

  2016cites this paper
• Hepatic Encephalopathy: From the Pathogenesis to the New Treatments

  2014cites this paper
• Nutritional Management of Hepatobiliary Diseases

  2013cites this paper
• Nutritional support for liver disease.

  2012cites this paper
• Pharmacotherapy for Hepatic Encephalopathy

  2010cites this paper
• Hepatic encephalopathy as a complication of liver cirrhosis: An Asian perspective

  2010cites this paper
• 8 Leverziekten, ondervoeding en voeding

  2009cites this paper
• [Update on the management of hepatic encephalopathy].

  2008cites this paper
• Actualización en el tratamiento de la encefalopatía hepática

  2008cites this paper
• Review article: the current pharmacological therapies for hepatic encephalopathy

  2007cites this paper
• Evaluation of serum L-phenylalanine concentration as indicator of liver disease in dogs: a pilot study.

  2007cites this paper
• A Randomized, Controlled, Clinical Study of Thymosin Alpha‐1 Versus Interferon‐Alpha in Chinese Patients with Chronic Hepatitis B Lacking Hepatitis B Envelope Antigen

  2005cites this paper
• Treatment of hepatic encephalopathy - systematic Cochrane reviews of randomised clinical trials

  2005cites this paper
• Effects of branched-chain amino acids on DNA synthesis and proliferation in primary cultures of adult rat hepatocytes.

  2005cites this paper
• Treatments for hepatitis B.

  2004cites this paper
• Branched-chain amino acids for hepatic encephalopathy.

  2003cites this paper
• Hepatic encephalopathy: a review.

  2003cites this paper
• Oral supplementation of branched-chain amino acid improves nutritional status in elderly patients on chronic haemodialysis.

  2001cites this paper
• Hepatic encephalopathy

  2001cites this paper
• Hepatitis C; a retrospective study, literature review, and naturopathic protocol.

  2000cites this paper
• Brain edema and portal‐systemic encephalopathy

  2000cites this paper
• Pilot study of combination therapy with ribavirin and interferon alfa for the retreatment of chronic hepatitis B e antibody–positive patients

  2000cites this paper
• Diet and allograft rejection.

  2000cites this paper
• Diagnosis and treatment of hepatic encephalopathy.

  2000cites this paper
• Aspects nutritionnels des hépatopathies chroniques stables

  1999cites this paper
• Dietary management of hepatic encephalopathy

  1999cites this paper
• Effects of a Branched-Chain Amino Acid-Enriched Diet on Chronic Hepatic Encephalopathy in Dogs

  1999cites this paper
• Drug Treatment of Encephalopathy Associated with Fulminant Liver Failure

  1999cites this paper
• INTERFERON THERAPY OF HEPATITIS B

  1999cites this paper
• Polyarteritis nodosa associated with precore mutant hepatitis B virus infection

  1998cites this paper
• Effects of branched-chain-enriched amino acid solution on insulin and glucagon secretion and blood glucose level in liver cirrhosis.

  1998cites this paper
• Nutritional aspects of the management of chronic hepatic encephalophathy

  1998cites this paper
• Role of tryptophan in the elevated serotonin-turnover in hepatic encephalopathy

  1998cites this paper
• Treatment of hepatic encephalopathy.

  1997cites this paper
• Leucine metabolism in partially hepatectomized rats.

  1997cites this paper
• Energy and protein requirements of patients with chronic liver disease.

  1997cites this paper
• Portal systemic encephalopathy.

  1997cites this paper
• [Therapy of hepatic encephalopathy].

  1996cites this paper
• Severe recurrent hepatic encephalopathy that responded to oral branched chain amino acids.

  1996cites this paper
• Leucine metabolism in rats with cirrhosis.

  1996cites this paper
• Overview of randomized clinical trials of oral branched-chain amino acid treatment in chronic hepatic encephalopathy.

  1996cites this paper
• Response of phenylalanine and leucine kinetics to branched chain-enriched amino acids and insulin in patients with cirrhosis.

  1996cites this paper
• Recent results in the treatment of chronic B virus hepatitis.

  1995cites this paper
• Nutrition in Liver Disease

  1995cites this paper
• Nutritional support during liver failure.

  1995cites this paper
• Rolling review: the treatment of major complications of cirrhosis.

  1994cites this paper
• Diagnosis and therapy of hepatic encephalopathy.

  1994cites this paper
• [Hepatic coma].

  1994cites this paper
• The treatment of major complications of cirrhosis

  1994cites this paper
• Brain indoles in human hepatic encephalopathy

  1993cites this paper
• Long-term treatment of latent portosystemic encephalopathy with branched-chain amino acids. A double-blind placebo-controlled crossover study.

  1993cites this paper
• [Valine and branched-chain amino acids in the treatment of hepatic encephalopathy].

  1993cites this paper
• Clinical manifestations and therapy of hepatic encephalopathy.

  1993cites this paper
• [What is guaranteed in the therapy of hepatic encephalopathy?].

  1993cites this paper
• Fulminant hepatic failure.

  1993cites this paper
• Nutritional Therapies in Liver Disease

  1991cites this paper
• Intérêt de l'administration par voie orale d'acides aminés à chaîne ramifiée chez le cirrhotique encéphalopathe chronique

  1991cites this paper